PFNX - Pfenex Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PFNX (1478121)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
32 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S32-1-4+0-25

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-01-06
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.50-400556,6560%-$3,800-2-20-19
M
2017-01-04
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.50-7,710556,754-1%-$73,268+4-3-18
M
2016-12-28
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.66-24,104558,650-4%-$232,742-2+2-12
M
2016-12-23
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.58-104,600564,577-16%-$1,002,182+1-1-14
M
2016-12-21
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.61-10,896590,299-2%-$104,677+4-3-11
D
2016-11-21
PFNXLady PatriciaChief Accounting OfficerS - Sale+OE$9.87-2,0002,800-42%-$19,736+60+1
2016-11-15
PFNXLucy Patrick K.Chief Business OfficerS - Sale$10.04-5,000102,090-5%-$50,208+7-5-12
D
2016-08-18
PFNXLady PatriciaChief Accounting OfficerS - Sale+OE$9.42-2,0002,800-42%-$18,836-3-12-7-11
D
2016-05-24
PFNXLady PatriciaChief Accounting OfficerS - Sale+OE$6.52-2,0002,100-49%-$13,043-1+15+32+56
2015-12-15
PFNXDow Chemical Co /de/10%S - Sale$11.75-600,0002,221,428-21%-$7,050,000-2-2-26-34
2015-12-03
PFNXLucy Patrick K.Chief Business OfficerS - Sale$14.15-1,500105,690-1%-$21,231+1-9-11-41
2015-12-01
PFNXTalbot Henry W. Jr.VP of OperationsS - Sale$15.08-2,000118,678-2%-$30,168-10-17-15-49
2015-12-01
PFNXLiang Bertrand C.CEOS - Sale$14.88-5,000522,466-1%-$74,417-10-17-15-49
D
2015-11-18
PFNXLady PatriciaChief Accounting OfficerS - Sale+OE$14.05-2,0001,400-59%-$28,101+3+10-14-53
2015-11-04
PFNXLucy Patrick K.Chief Business OfficerS - Sale$17.54-1,500107,190-1%-$26,305+1-12-20-50
2015-11-02
PFNXLiang Bertrand C.CEOS - Sale$18.01-5,000527,466-1%-$90,069-4-6-18-51
2015-10-02
PFNXLucy Patrick K.Chief Business OfficerS - Sale$14.98-1,500108,690-1%-$22,477-4-8+4-45
2015-10-01
PFNXLiang Bertrand C.CEOS - Sale$14.78-5,000532,466-1%-$73,905+5-4+9-41
D
2015-09-03
PFNXLady PatriciaChief Accounting OfficerS - Sale+OE$20.48-2,0001,400-59%-$40,960+2+5-14-55
2015-09-03
PFNXLucy Patrick K.Chief Business OfficerS - Sale$20.91-1,500110,190-1%-$31,365+2+5-14-55
2015-09-01
PFNXLiang Bertrand C.CEOS - Sale$21.02-5,000536,980-1%-$105,124-4-4-28-63
2015-08-05
PFNXLucy Patrick K.Chief Business OfficerS - Sale$20.75-1,500110,990-1%-$31,1250-4+9-48
2015-08-03
PFNXLiang Bertrand C.CEOS - Sale$20.84-5,000541,980-1%-$104,209-1-12+1-56
2015-07-06
PFNXLucy Patrick K.Chief Business OfficerS - Sale$19.17-1,500112,490-1%-$28,750-9+6+2-44
2015-07-01
PFNXLiang Bertrand C.CEOS - Sale$19.63-5,000546,980-1%-$98,148+5-1+10-34
2015-06-03
PFNXLucy Patrick K.Chief Business OfficerS - Sale$20.08-1,500113,990-1%-$30,120-8-13-3-25
2015-06-01
PFNXLiang Bertrand C.CEOS - Sale$18.70-5,000551,980-1%-$93,509+2-5-3-21
2015-05-04
PFNXLucy Patrick K.Chief Business OfficerS - Sale$13.25-1,500115,490-1%-$19,880+10+55+37
2015-05-01
PFNXLiang Bertrand C.CEOS - Sale$13.49-5,000556,980-1%-$67,440+6+5+54+38
2015-04-29
PFNXSignet Healthcare Partners Accredited Partnership III LP10%S - Sale$14.57-1,907,767592,978-76%-$27,796,165-5-7+35+18
2015-04-29
PFNXGale James CDirS - Sale$14.57-1,907,767592,978-76%-$27,796,165-5-7+35+18
2015-04-29
PFNXDow Chemical Co /de/10%S - Sale$14.57-2,232,2332,821,428-44%-$32,523,635-5-7+30+21

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top